Haim Breitbart of Bar-Ilan University in Israel will design and test antisense molecules that will inactivate specific genes within sperm that are essential to the fertilization process. If successful, these antisense molecules can be used to develop a reversible oral male contraceptive.
Grant ID
OPP1017978
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False